文献速递腹部MR

钆塞酸增强MRI可预测肝移植后肝细胞癌复发

Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
PubMed 文献 · Eur Radiol · 2019-08-30

这项多中心回顾性研究纳入122例接受活体供肝移植的未治疗肝细胞癌受者,评估术前钆塞酸增强MRI对肿瘤分期和复发的预测价值。多因素分析显示超出米兰标准和肝胆期瘤周低信号是肝癌复发的独立预测因子,术前MRI对米兰标准分级的准确率为90.2%。

要点

  • 肝胆期瘤周低信号是肝癌复发的独立预测因子(HR 18.30)。
  • 超出米兰标准也是独立预测因子(HR 3.54)。
  • 术前MRI判断米兰标准的准确率为90.2%。

核心结论

  • 术前钆塞酸增强MRI可能有助于预测肝细胞癌复发风险。
  • 超出米兰标准和肝胆期瘤周低信号是肝癌复发的独立预测因子。
  • 肝胆期瘤周低信号与更差的肿瘤分级和微血管侵犯显著相关。

研究设计与样本

  • 多中心回顾性研究,纳入2009年1月至2013年12月间122例接受活体供肝移植的未治疗肝细胞癌受者,术前均行钆塞酸增强MRI。
  • 以移植肝病理检查分析米兰标准、肿瘤分级和微血管侵犯,评估无病生存期。

关键影像表现/征象

  • 肝胆期瘤周低信号与更差的肿瘤分级显著相关(p=0.010)。
  • 肝胆期瘤周低信号与微血管侵犯显著相关(p<0.001)。

诊断标准与关键数值

  • 术前MRI对照移植肝病理,判断米兰标准的准确率为90.2%。
  • 超出米兰标准预测复发的HR为3.54(95%CI 1.13-11.12,p=0.030)。
  • 肝胆期瘤周低信号预测复发的HR为18.30(95%CI 4.33-77.34,p<0.001)。
  • 1年、3年、5年和7年无病生存率分别为93.3%、90.7%、88.9%和86.1%。
  • 超出米兰标准但无肝胆期瘤周低信号者与米兰标准内患者的5年无病生存率无显著差异(92.2% vs. 92.9%,p=0.438)。

临床应用与阅片要点

  • 术前钆塞酸增强MRI可能辅助预测肝细胞癌肝移植后复发风险,阅片时需关注肝胆期瘤周低信号。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the value of preoperative gadoxetic acid-enhanced MRI for tumor staging and recurrence prediction of hepatocellular carcinoma (HCC) after primary liver transplantation (LT).

METHODS: This multicenter retrospective study included 122 recipients who underwent living donor LT (LDLT) for untreated HCC and pre-transplant gadoxetic acid-enhanced MRI from January 2009 to December 2013. Disease-free survival (DFS) was evaluated. Milan criteria, tumor grade, and microvascular invasion (MVI) were analyzed on the pathological examination of the explanted liver.

RESULTS: The 1-, 3-, 5-, and 7-year DFS rates were 93.3%, 90.7%, 88.9%, and 86.1%, respectively. In the multivariable analysis, independent predictors of HCC recurrence were "beyond the Milan criteria" (hazard ratio [HR], 3.54; 95% confidence interval [CI], 1.13-11.12; p = 0.030) and peritumoral hypointensity on hepatobiliary phase (HBP) (HR, 18.30; 95% CI, 4.33-77.34; p < 0.001). Pre-transplant MRI yielded a 90.2% accuracy to categorize the Milan criteria when compared with the explanted liver. Peritumoral hypointensity on HBP was significantly associated with a worse tumor grade (p = 0.010) and MVI (p < 0.001). The 5-year DFS rate in patients with "beyond the Milan criteria" but the absence of peritumoral hypointensity on HBP was not different from that in patients "within the Milan criteria" (92.2% vs. 92.9%, p = 0.438).

CONCLUSIONS: Pre-transplant gadoxetic acid-enhanced MRI may assist in the HCC recurrence risk prediction.

KEY POINTS: • Lesions beyond the Milan criteria and peritumoral hypointensity on hepatobiliary phase (HBP) were independent predictors of HCC recurrence. • Peritumoral hypointensity on HBP significantly associated with a worse tumor grade and microvascular invasion.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee S, Kim KW, Jeong WK, et al. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation. Eur Radiol. 2019. PMID: 31471754. doi:10.1007/s00330-019-06424-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。